{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:56:06Z","timestamp":1795042566209,"version":"4.10.2"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Childhood obesity is a significant problem. Obesity may alter the pharmacokinetics (PKs) of medications. Fentanyl is commonly used for procedural sedation, but there is a paucity of bolus dose fentanyl PK data in obese children. Better understanding of fentanyl PK in obese children would facilitate dosing recommendations. We conducted a study involving children with and without obesity to assess the potential differences in bolus dose fentanyl PK between the 2 groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We enrolled children 2 to 12 years of age with and without obesity, defined as &gt;95th percentile body mass index (BMI) for age and sex, undergoing elective tonsillectomy \u00b1 adenoidectomy. After induction, subjects had 2 intravenous (IV) lines placed in 2 different extremities: 1 for medications and IV fluids and 1 for obtaining blood aliquots for fentanyl concentration analysis. After administration of 1 mcg\/kg of fentanyl based on total body weight (TBW), blood sample collections for fentanyl concentration analysis were attempted at 5, 15, 30, 60, 90, and 120 minutes. Five-minute fentanyl concentrations were compared between obese and nonobese cohorts. Population PK analysis to examine the differences between obese and nonobese children was performed and included various body size descriptors, such as TBW, BMI, and fat-free mass (FFM), to examine their influence on model parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Half of the 30 subjects were obese. Mean fentanyl concentrations at 5 minutes were 0.53 ng\/mL for the nonobese group and 0.88 ng\/mL for the obese group, difference 0.35 ng\/mL (95% CI, 0.08\u20130.61 ng\/mL;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01). Population PK analysis showed that FFM was a significant covariate for the central volume of distribution. The potential clinical effect of an IV bolus dose of fentanyl based on TBW versus FFM in an obese child was assessed in a simulation using our model. 1 mcg\/kg fentanyl dose based on TBW resulted in an approximately 60% higher peak fentanyl effect site concentration than dosing based on FFM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our data demonstrated higher peak plasma fentanyl concentrations in obese compared to nonobese subjects. Population PK analysis found that FFM was a significant covariate for the central volume of distribution. Model simulation showed dosing of fentanyl in obese children based on TBW resulted in significantly higher peak concentrations than dosing based on FFM. Based on this modeling and the known concentration-effect relationship between fentanyl and adverse effects, our results suggest that bolus dosing of fentanyl in obese children should be based on FFM rather than TBW, particularly for procedures of short duration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006554","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:04:07Z","timestamp":1696604647000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Population Pharmacokinetics of Single Bolus Dose Fentanyl in Obese Children"],"prefix":"10.1213","volume":"138","author":[{"given":"Carol R.","family":"Okada","sequence":"first","affiliation":[{"name":"Division of Pediatric Critical Care, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Henthorn","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Zuk","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sempio","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Roosevelt","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda G.","family":"Ruiz","sequence":"additional","affiliation":[{"name":"New York Medical College School of Medicine, Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy N.","family":"Cohen","sequence":"additional","affiliation":[{"name":"New York Medical College School of Medicine, Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debnath","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital Colorado\/University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Galinkin","sequence":"additional","affiliation":[{"name":"US Anesthesia Partners, Greenwood Village, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004.","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2016.6361","article-title":"Trends in obesity prevalence among children and adolescents in the United States, 1988\u20131994 through 2013\u20132014.","volume":"315","author":"Ogden","year":"2016","journal-title":"JAMA"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ehb.2019.02.002","article-title":"Understanding recent trends in childhood obesity in the United States.","volume":"34","author":"Anderson","year":"2019","journal-title":"Econ Hum Biol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-3459","article-title":"Prevalence of obesity and severe obesity in US Children, 1999-2016.","volume":"141","author":"Skinner","year":"2018","journal-title":"Pediatrics"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/bja\/85.1.91","article-title":"Obesity in anaesthesia and intensive care.","volume":"85","author":"Adams","year":"2000","journal-title":"Br J Anaesth"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/adc.2009.163055","article-title":"Dosing dilemmas in obese children.","volume":"95","author":"Mulla","year":"2010","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2146\/ajhp140280","article-title":"Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.","volume":"72","author":"Ross","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"suppl 1","key":"R8-20250502","first-page":"i1616","article-title":"Dose adjustment of anaesthetics in the morbidly obese.","volume":"105","author":"Ingrande","year":"2010","journal-title":"Br J Anaesth"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000542-200409000-00008","article-title":"Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (\u201cpharmacokinetic mass\u201d).","volume":"101","author":"Shibutani","year":"2004","journal-title":"Anesthesiology"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/aei195","article-title":"Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients.","volume":"95","author":"Shibutani","year":"2005","journal-title":"Br J Anaesth"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40272-017-0216-6","article-title":"Use of fentanyl in adolescents with clinically severe obesity undergoing bariatric surgery: a pilot study.","volume":"19","author":"Vaughns","year":"2017","journal-title":"Paediatr Drugs"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jcph.1562","article-title":"Dosing of continuous Fentanyl infusions in obese children: a population pharmacokinetic analysis.","volume":"60","author":"Maharaj","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report.","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-015-0277-z","article-title":"Prediction of fat-free mass in children.","volume":"54","author":"Al-Sallami","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/ALN.0000000000001634","article-title":"An allometric model of remifentanil pharmacokinetics and pharmacodynamics.","volume":"126","author":"Eleveld","year":"2017","journal-title":"Anesthesiology"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1002\/jssc.201100422","article-title":"A low blood volume LC-MS\/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children.","volume":"34","author":"Clavijo","year":"2011","journal-title":"J Sep Sci"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/00003246-199307000-00012","article-title":"Pharmacokinetics of continuous infusions of fentanyl in critically ill children.","volume":"21","author":"Katz","year":"1993","journal-title":"Crit Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000542-198811000-00008","article-title":"Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age.","volume":"69","author":"Gauntlett","year":"1988","journal-title":"Anesthesiology"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1213\/00000539-198603000-00002","article-title":"Pharmacokinetics of fentanyl in neonates.","volume":"65","author":"Koehntop","year":"1986","journal-title":"Anesth Analg"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03015333","article-title":"Plasma concentrations of fentanyl in infants, children and adults.","volume":"34","author":"Singleton","year":"1987","journal-title":"Can J Anaesth"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/CCM.0000000000001347","article-title":"Population pharmacokinetics of fentanyl in the critically ill.","volume":"44","author":"Choi","year":"2016","journal-title":"Crit Care Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/bcp.12903","article-title":"Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.","volume":"81","author":"Van Driest","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000542-199612000-00007","article-title":"Pharmacokinetic model-driven infusion of fentanyl in children.","volume":"85","author":"Ginsberg","year":"1996","journal-title":"Anesthesiology"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40262-017-0569-6","article-title":"Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review.","volume":"57","author":"Ziesenitz","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1213\/ANE.0000000000001257","article-title":"Allometry, Shallometry!.","volume":"122","author":"Fisher","year":"2016","journal-title":"Anesth Analg"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metatdata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.103.6.820","article-title":"Relations of stroke volume and cardiac output to body composition: the strong heart study.","volume":"103","author":"Collis","year":"2001","journal-title":"Circulation"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight.","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/archdischild-2016-311696","article-title":"Getting the dose right for obese children.","volume":"102","author":"Anderson","year":"2017","journal-title":"Arch Dis Child"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00000542-200308000-00014","article-title":"Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.","volume":"99","author":"Minto","year":"2003","journal-title":"Anesthesiology"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-199902000-00034","article-title":"A review of the use of fentanyl analgesia in the management of acute pain in adults.","volume":"90","author":"Peng","year":"1999","journal-title":"Anesthesiology"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/ALN.0000000000003593","article-title":"Meta-analysis of ketamine pharmacokinetics: Lots of work done but still lots to do.","volume":"133","author":"Eleveld","year":"2020","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:00Z","timestamp":1786113120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006554","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}